Trxade Group Q2 EPS $(0.13) Misses $(0.08) Estimate
Trxade Group (NASDAQ:MEDS) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.08) by 62.5 percent. This is a 23.53 percent increase over losses of $(0.17) per share from the